These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council]. van Aken WG Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1444-7. PubMed ID: 11503311 [TBL] [Abstract][Full Text] [Related]
24. What future means to management of blood centres. van Aken WG Vox Sang; 1998; 74 Suppl 2():115-8. PubMed ID: 9704432 [No Abstract] [Full Text] [Related]
25. Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies. Yang H; Huang Y; Gregori L; Asher DM; Bui T; Forshee RA; Anderson SA Transfusion; 2017 Apr; 57(4):924-932. PubMed ID: 28261810 [TBL] [Abstract][Full Text] [Related]
26. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Hewitt PE; Llewelyn CA; Mackenzie J; Will RG Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834 [TBL] [Abstract][Full Text] [Related]
27. Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues. Sandler SG Curr Opin Hematol; 2006 Nov; 13(6):445-6. PubMed ID: 17053456 [No Abstract] [Full Text] [Related]
28. NBS approaches to the approval of suppliers of leucodepletion systems. Smith KJ Transfus Sci; 1998 Dec; 19(4):371-2. PubMed ID: 10351159 [No Abstract] [Full Text] [Related]
29. Operational and research approaches to universal leucodepletion in Scotland. Prowse C Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158 [No Abstract] [Full Text] [Related]
31. UK patient first to contract vCJD via blood transfusion. Sibbald B CMAJ; 2004 Mar; 170(7):1087. PubMed ID: 15051685 [No Abstract] [Full Text] [Related]
32. New variant Creutzfeldt-Jakob disease and the blood supply: is it time to face the music? Hoey J; Giulivi A; Todkill AM CMAJ; 1998 Sep; 159(6):669-70. PubMed ID: 9780967 [No Abstract] [Full Text] [Related]
33. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US. Ponte ML PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547 [TBL] [Abstract][Full Text] [Related]
34. Blood supplies hit by vCJD fear. Strachan-Bennett S Nurs Times; 2004 Jan 6-12; 100(1):6. PubMed ID: 14735624 [No Abstract] [Full Text] [Related]
36. UK approach to assessing assays and filters designed to reduce the risk of transfusion-transmitted vCJD. Thomas S; Turner ML; Williamson LM Transfus Clin Biol; 2013 Sep; 20(4):405-11. PubMed ID: 23928183 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease. Cooper JK; Andrews N; Ladhani K; Bujaki E; Minor PD Vox Sang; 2013 Oct; 105(3):196-204. PubMed ID: 23772892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]